Single or Repeat Dose of G03-52-01 in Adult Subjects
Public ClinicalTrials.gov record NCT05348993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Immunogenicity of G03-52-01 in Adult Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2, randomized, double-blind, placebo-controlled single or repeat dose trial
Study identification
- NCT ID
- NCT05348993
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 622 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2022 (Actual)
- Primary completion
- Feb 18, 2025 (Actual)
- Completion
- Feb 18, 2025 (Actual)
- Last update posted
- Feb 17, 2026
2022 – 2025
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AMR Mobile | Mobile | Alabama | 36608 | — |
| AMR Tempe | Tempe | Arizona | 85281 | — |
| AMR Fort Myers | Fort Myers | Florida | 33912 | — |
| AMR Miami | Miami | Florida | 33134 | — |
| AMR El Dorado | El Dorado | Kansas | 67042 | — |
| AMR Newton | Newton | Kansas | 67114 | — |
| AMR Wichita West | Wichita | Kansas | 67205 | — |
| AMR Wichita East | Wichita | Kansas | 67207 | — |
| AMR Lexington | Lexington | Kentucky | 40509 | — |
| AMR New Orleans | New Orleans | Louisiana | 70119 | — |
| AMR Kansas City | Kansas City | Missouri | 64114 | — |
| AMR Las Vegas | Las Vegas | Nevada | 89119 | — |
| AMR Norman | Norman | Oklahoma | 73069 | — |
| AMR Knoxville West | Knoxville | Tennessee | 37909 | — |
| AMR Norfolk | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05348993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05348993 live on ClinicalTrials.gov.